Counterfeiters Increasingly Target Chronic Illness - Reps. Buyer, Matheson
Executive Summary
Drugs to treat chronic conditions are increasingly being counterfeited, a problem that helps underscore the need for electronic pedigree legislation, Rep. Steve Buyer, R-Ind., said at an April 22 press conference to promote the "Safeguarding America's Pharmaceuticals Act.
You may also be interested in...
EC Considers API Regulation In Effort To Fight Counterfeit Drugs
Stricter requirements for active ingredients, a ban on repackaging, and mandatory company audits of their trading partners are on the table in the European Commission's quest for antidotes to a growing influx of counterfeit medicines
EC Considers API Regulation In Effort To Fight Counterfeit Drugs
Stricter requirements for active ingredients, a ban on repackaging, and mandatory company audits of their trading partners are on the table in the European Commission's quest for antidotes to a growing influx of counterfeit medicines
Foreign Drug Inspections Would Be Funded By Registration Fees In Draft Bill
FDA inspections of overseas drug producers would be supported by annual registration fees under a legislative "discussion draft" being circulated by House Energy and Commerce Committee Chairman John Dingell, D-Mich